Related Experiment Video
Updated: May 31, 2026
05:39
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
Published on: November 30, 2021
Hypercalcemia in extremely low birth weight neonates
Saudamini Vijay Nesargi1, Swarna Rekha Bhat, Suman Rao P N
1Division of Neonatology, Department of Pediatrics, St. John's Medical College Hospital, Koramangala, Bangalore 34, India. saudamini_nesargi@yahoo.com
Indian Journal of Pediatrics
|July 7, 2011
Summary
Hypercalcemia is uncommon in newborns but can occur with low phosphate levels in extremely low birth weight (ELBW) infants receiving parenteral nutrition lacking sufficient phosphate.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
- Nutritional Science
Background:
- Hypercalcemia is a rare condition in neonates.
- It is often linked to hypophosphatemia in specific infant populations.
- Parenteral nutrition is a critical intervention for certain newborns.
Purpose of the Study:
- To investigate the association between hypercalcemia and hypophosphatemia in extremely low birth weight (ELBW) neonates.
- To understand the role of parenteral nutrition in the development of these electrolyte imbalances.
- To highlight the importance of adequate phosphate supplementation in ELBW infants.
Main Methods:
- Retrospective chart review of ELBW neonates.
- Analysis of electrolyte levels (calcium and phosphate) in neonates receiving parenteral nutrition.
- Correlation of electrolyte levels with phosphate supplementation protocols.
Main Results:
- Extremely low birth weight (ELBW) neonates on parenteral nutrition showed a higher incidence of hypercalcemia when phosphate supplementation was inadequate.
- A significant inverse relationship was observed between calcium and phosphate levels.
- Hypophosphatemia was a consistent finding in neonates with hypercalcemia.
Conclusions:
- Inadequate phosphate supplementation during parenteral nutrition is a risk factor for hypercalcemia in ELBW neonates.
- Monitoring and optimizing phosphate levels are crucial for preventing hypercalcemia in this vulnerable population.
- This finding underscores the need for careful nutritional management in neonatal intensive care units.
Related Concept Videos
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
00:51Synthesis and Functions of Calcitonin
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...